Özet:

Background: In our study, we aimed to investigate the effects of clinical and imaging findings on the survival of patients with intracranial metastasis. Materials-Methods: Data of 66 patients with intracranial metastases who applied to Mersin University Faculty of Medicine, Brain and Nerve Surgery outpatient clinic and Emergency Department between January 1, 2009 and November 10, 2013 were retrospectively analyzed. Result: Of the patients, 39 (59.1%) were male and 27 (40.9%) were female. The average age of the patients was 57 years. Among the cases, 29 (43.9%) lung cancer, 6 (9.2%) malignant melanoma, 5 (7.5%) gastrointestinal system tumors, 4 (6.1%) lymphoma, 10 (15.2%) other tumors (renal cell ca, testicular ca, ovarian ca, bladder ca) were present. Metastasis caused by cancer of unknown primary was detected in 3 (4.5%) of the patients. It was found that 36 (54.6%) of metastases were solitary and 30 (45.4%) were multiple. The brain metastases, 47 (71%) were supratentorial, 12 (18%) were infratentorial, 7 (11%) were both supratentorial and infratentorial. 30 (45.5%) of the patients were treated surgically. Surgical treatment was not applied to 36 (54.5%) patients. The average survival of multiple metastases was 6.1 months, and 8.4 months for solitary metastases. The mean life expectancy was found to be 8.7 months in patients who underwent surgical treatment and 5.6 months in patients who did not undergo surgical treatment. Conclusion: Factors such as the patient's general condition, neurological condition, and the types of treatment administered affect their lifespan.

Anahtar Kelimeler: